Toxicity by NSAIDs. Counteraction by Stable Gastric Pentadecapeptide BPC 157

E-ISSN： 1873-4286|19|1|76-83

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.1, 2013-01, pp. : 76-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Focus on Ulcerative Colitis: Stable Gastric Pentadecapeptide BPC 157

Current Medicinal Chemistry, Vol. 19, Iss. 1, 2012-01 ,pp. : 126-132

Bentham Science Publishers

Access to resources Recommend Favorite

Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract

Current Pharmaceutical Design, Vol. 17, Iss. 16, 2011-06 ,pp. : 1612-1632

Bentham Science Publishers

Access to resources Recommend Favorite

Stable Gastric Pentadecapeptide BPC 157-NO-system Relation

Current Pharmaceutical Design, Vol. 20, Iss. 7, 2014-02 ,pp. : 1126-1135

Bentham Science Publishers

Access to resources Recommend Favorite

Revised Robert's Cytoprotection and Adaptive Cytoprotection and Stable Gastric Pentadecapeptide BPC 157. Possible Significance and Implications for Novel Mediator

Current Pharmaceutical Design, Vol. 16, Iss. 10, 2010-04 ,pp. : 1224-1234

Bentham Science Publishers

Access to resources Recommend Favorite

Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia). Full and distended stomach, and vascular response.

By Sikiric P. Seiwerth S. Brcic L. Blagaic A. Zoricic I. Sever M. Klicek R. Radic B. Keller N. Sipos K. Jakir A. Udovicic M. Tonkic A. Kokic N. Turkovic B. Mise S. Anic T.

Inflammopharmacology, Vol. 14, Iss. 5-6, 2006-12 ,pp. : 214-221

Springer Publishing Company

Access to resources Recommend Favorite